Pretreatment Masseter Muscle Volume Predicts Survival in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy.
Umur Anıl PehlivanEfsun SomayBusra YilmazAli Ayberk BesenHuseyin MertsoyluUgur SelekErkan TopkanPublished in: Journal of clinical medicine (2023)
The findings of the current retrospective research suggest that pretreatment TMMV is a promising indicator for predicting survival outcomes in LA-NPC patients receiving definitive CCRT.